MAR 12, 2018 06:40 PM PDT

Pond Virus Cures Patient's Antibiotic-resistant Infection

WRITTEN BY: Carmen Leitch

An 80-year old doctor was stricken by a deadly bacterial infection, and doctors stopped it with a virus taken from a pond in Connecticut. In what seems like the plot of a movie, the virus, a type of bacteriophage, had been found to have an affinity for Pseudomonas aeruginosa. That same bacterium was infecting a patient after heart surgery and was resisting all antibiotic treatments. The team reported the successful treatment of the infection with the virus, in the journal Evolution, Medicine, and Public Health.

Pseudomonas aeruginosa bacteria / Credit: Centers for Disease Control

The doctor needed to undergo an aortic arch replacement operation; after the surgery, an infection developed, and huge doses of antibiotics were necessary to keep him alive. The bacterium causing the illness was resistant to treatment, so his physician, Dr. Deepak Narayan, listened to researcher Benjamin Chan when the call came. 

There had been an expedition at Dodge Pond in Connecticut that yielded a bacteriophage; they are a type of virus that can kill specific bacterial strains. Chan had been screening samples, looking for bacteriophages in the hopes of findings one that could kill a drug-resistant infection. As the problem of drug resistance grows, we may have to look to bacteriophages as a new kind of therapeutic. This study has suggested that it could work.

Narayan directly administered the virus to the patient; hundreds of thousands of bacteriophage particles were added right to his chest. The treatment worked; the virus killed the  Pseudomonas aeruginosa and the patient recovered from the infection. 

The bacteriophage acts by attaching to proteins that reside on the surface of bacteria, explained the study co-author Paul Turner, Yale’s Elihu Professor of Ecology and Evolutionary Biology and acting dean of science.  The bacteriophage, called OMKO1, binds to surface proteins, which can pump antibiotics out of the bacteria cell and allow it to survive a drug treatment. The bacteriophage OMKO1 eliminates bacteria with those pumps, leaving only bacteria that antibiotics can act on.

“The bacteria are backed into an evolutionary corner,” Turner explained.

The work continues, as the scientists assess other bacteriophages to find ones that can kill other pathogens that resist treatment, such as E. Coli and Klebsiella pneumoniae.

“This new approach to countering that threat grew out of basic research on the process of evolution and also shows the value of biodiversity,” said Sam Scheiner, program director in the National Science Foundation’s (NSF) Division of Environmental Biology.

Sources: Yale NewsEvolution, Medicine, and Public Health

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
NOV 17, 2019
Microbiology
NOV 17, 2019
Cataloging the Microbial Genes in the Human Microbiome
The human body carries a large community of microbes, and the ones living in our gastrointestinal tract exert a powerful influence on our biology....
NOV 17, 2019
Microbiology
NOV 17, 2019
Antibiotic Resistance Rises in Wild Dolphins
Antibiotic resistant bacteria are considered a major threat to public health, which is expected to get more serious....
NOV 17, 2019
Immunology
NOV 17, 2019
Flu Shot Less Effective Due to Overuse of Antibioitics
New research out of the Stanford University School of Medicine shows that the consequence of overuse of antibiotics lowers the effectiveness of the seasona...
NOV 17, 2019
Drug Discovery & Development
NOV 17, 2019
New Potential Early Stage Treatment for Parkinson's
Parkinson’s Disease is the second most common neurodegenerative condition, affecting 35 million people globally. Currently without a cure, researcher...
NOV 17, 2019
Genetics & Genomics
NOV 17, 2019
A More Precise Version of CRISPR/Cas9 is Created
A more accurate version of Cas9 has been created, reducing the number of off-target effects. It may be better suited for use in gene therapy....
NOV 17, 2019
Microbiology
NOV 17, 2019
Raising Awareness of Valley Fever
Valley fever primarily occurs in Arizona and California, and infects around 10,000 people every year....
Loading Comments...